Tharimmune Inc (THAR)
0.326
-0.06
(-16.52%)
USD |
NASDAQ |
May 22, 16:00
0.3253
0.00 (0.00%)
After-Hours: 20:00
Tharimmune Cash from Investing (TTM): 0.00 for March 31, 2024
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| Date | Value |
|---|---|
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
Mar 2023
--
Maximum
Mar 2023
--
Average
--
Median
Mar 2023
Cash from Investing (TTM) Benchmarks
| Ironwood Pharmaceuticals Inc | -1.026B |
| Mirum Pharmaceuticals Inc | -134.23M |
| NovaBay Pharmaceuticals Inc | 1.062M |
| Palatin Technologies Inc | 9.41M |
| iBio Inc | 1.044M |